New results from antibody trial for tetraplegic patients
Prof. Armin Curt and his team have been conducting a Europe-wide phase II clinical trial with NG-101, a recombinant human antibody. NG-101 neutralizes the membrane protein Nogo-A and thus promotes neural repair and functional recovery […]